AMITYVILLE, N.Y.--(BUSINESS WIRE)--May. 9, 2013-- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is scheduled to make an investor presentation at the Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, 2013, at 10:00 a.m. Pacific Time.
A live audio webcast of the Company's presentation can be accessed on the Investor Relations page of the Company's website:
http://www.hitechpharm.com
The webcast will be archived within one hour after the live event ...
AMITYVILLE, N.Y.--(BUSINESS WIRE)--Apr. 30, 2013-- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that its ECR Pharmaceuticals division re-launched Zolpimist® Oral Spray (zolpidem tartrate) and DexPak® Taperpaks (dexamethasone tablets) through its proprietary sales force at a series of launch meetings commencing this week.
Additionally, ECR has divested its interest in non-core products Hylase® and Orbivan®. Hylase was divested for a one-time payment in January, and Orbivan® was di...
AMITYVILLE, N.Y.--(BUSINESS WIRE)--Apr. 29, 2013-- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is scheduled to make an investor presentation at the Needham 12th Annual Healthcare Conference Tuesday, April 29, 2013, at 10:40 a.m. Eastern Time.
A live audio webcast of the Company's presentation can be accessed on the Investor Relations page of the Company's website:
http://www.hitechpharm.com
The webcast will be archived within one hour after the live event and will be...
AMITYVILLE, N.Y.--(BUSINESS WIRE)--Mar. 7, 2013-- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today reported results for the Company's fiscal third quarter ended January 31, 2013.
Quarterly Results
Net sales for the three months ended January 31, 2013 were $64,331,000, an increase of $8,706,000 or 16% compared to the net sales of $55,625,000, for the three months ended January 31, 2012.
Net sales for generic pharmaceuticals for the three months ended January 31, 2013 were $54,148,000, an in...
AMITYVILLE, N.Y.--(BUSINESS WIRE)--Mar. 4, 2013-- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) announced that the Company will release results for its third quarter of Fiscal Year 2013 ended January 31, 2013, prior to the market opening on Thursday March 7, 2013 and will hold a conference call to discuss its financial results at 10 a.m. Eastern Time.
To access the conference call, dial toll free 800-798-2864, or 617-614-6206 for international callers, five minutes before the conference. The pass...
AMITYVILLE, N.Y.--(BUSINESS WIRE)--Feb. 26, 2013-- Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is scheduled to make an investor presentation at the 2013 RBC Capital Markets' Healthcare Conference Wednesday, February 27, 2013, at 11:00 a.m. Eastern Standard Time.
A live audio webcast of the Company's presentation can be accessed on the Investor Relations page of the Company's website:
http://www.hitechpharm.com
The webcast will be archived within one hour after the li...
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.
